机译:Ⅰ/Ⅱ期多肽IMA950 / poly-ICLC疫苗在初诊成人恶性星形细胞瘤患者中的安全性和免疫原性试验
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
Geneva Univ Hosp, Dept Pathol, Div Neuropathol, Geneva, Switzerland;
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland;
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland;
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland|CHUV Univ Hosp, Dept Clin Neurosci, Lausanne, Switzerland|CHUV Univ Hosp, Dept Oncol, Lausanne, Switzerland|Univ Lausanne, Lausanne, Switzerland;
Geneva Univ Hosp, Dept Neurosci, Neurosurg Div, Geneva, Switzerland;
Geneva Univ Hosp, Dept Neurosci, Neurosurg Div, Geneva, Switzerland;
Geneva Univ Hosp, Dept Pathol, Div Neuropathol, Geneva, Switzerland;
Geneva Univ Hosp, Dept Pathol, Div Neuropathol, Geneva, Switzerland;
Geneva Univ Hosp, Dept Imaging & Med Informat Sci, Neuroradiol Div, Geneva, Switzerland;
Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Div Oncol, Geneva, Switzerland;
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland;
Geneva Univ Hosp, Dr Dubois Ferriere Dinu Lipatti Res Fdn, Dept Oncol, Clin Res Unit, Geneva, Switzerland|Geneva Univ Hosp, Lab Tumor Immunol, Geneva, Switzerland|Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland|Univ Geneva, Dept Internal Med Specialties, Translat Res Ctr Oncohematol, Geneva, Switzerland;
glioma; IMA950; immune response; peptide vaccine; poly-ICLC;
机译:在新诊断的成人恶性星形细胞瘤患者中,多肽IMA950 / Poly-ICLC疫苗的多肽IMA950 / Poly-ICLC疫苗的Ⅰ阶段Ⅰ/Ⅱ试验性和免疫原性
机译:一项癌症研究英国首次在新诊断为胶质母细胞瘤的患者中进行IMA950(新型多肽治疗疫苗)的人类I期试验
机译:聚-ICLC放射治疗新诊断的幕上胶质母细胞瘤成年患者的一项II期临床试验:北美脑肿瘤联合会(NABTC01-05)。
机译:一种双盲,随机期II试验,对健康成人的26岁的26岁群体的疫苗疫苗
机译:城市安全网患者人群中被诊断患有慢性疼痛和抑郁症的成年患者中的急诊科服务。
机译:在新诊断的成人恶性星形细胞瘤患者中I / II型试验试验的多肽IMA950 / Poly-ICLC疫苗的免疫原性
机译:IMA950多肽疫苗与Poly-ICLC辅助,与新诊断的HLA-A2胶质母细胞瘤患者的标准治疗组合
机译:加利福尼亚州Lambarn的成人和儿童rVsVG ZEBOV Gp疫苗的I期安全性和免疫原性试验。